Buprixa 0.3 mg Solution is a Health Canada–registered veterinary drug (DIN 02542536) held by Zoetis Canada Inc, containing Buprenorphine (Buprenorphine Hydrochloride). Health Canada lists its status as Approved (status date 30 Jan 2024). Nexara Health has matched 862 registrations of Buprenorphine (Buprenorphine Hydrochloride) across 28 other regulated markets.
Health Canada registration
| DIN | 02542536 |
|---|---|
| Brand name | Buprixa |
| Active ingredient | Buprenorphine (Buprenorphine Hydrochloride) |
| Strength | 0.3 mg |
| Dosage form | Solution |
| Route | Intramuscular |
| Company | Zoetis Canada Inc |
| Status | Approved — 30 Jan 2024 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Buprenorphine (Buprenorphine Hydrochloride) registered in other markets
862 registrations of the same molecule in 28 national registries outside Canada (first 120 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Australia | B-Patch | IU | Transdermal patch 20 mg | GE | PBS | |
| Australia | B-Patch | IU | Transdermal patch 15 mg | PL | PBS | |
| Australia | Bupredermal | Tx | Transdermal patch 5 mg | GE | PBS | |
| Australia | Bupredermal | Tx | Transdermal patch 10 mg | PL | PBS | |
| Australia | Buprenorphine Sandoz | Sz | Transdermal patch 25 mg | GE | PBS | |
| Australia | Buvidal Monthly | Ur | Injection (modified release) 160 mg in 0.45 mL pre-filled syringe | CA | PBS | |
| Australia | Buvidal Monthly | Ur | Injection (modified release) 128 mg in 0.36 mL pre-filled syringe | CA | PBS | |
| Australia | Buvidal Monthly | Ur | Injection (modified release) 64 mg in 0.18 mL pre-filled syringe | CA | PBS | |
| Austria | Astec 35 mcg/h transdermales Pflaster | — | 5St | green box | eEKO (Erstattungskodex) | |
| Austria | Astec 35 mcg/h transdermales Pflaster | — | 10St | green box | eEKO (Erstattungskodex) | |
| Austria | Astec 52,5 mcg/h transdermales Pflaster | — | 10St | green box | eEKO (Erstattungskodex) | |
| Austria | Astec 52,5 mcg/h transdermales Pflaster | — | 5St | green box | eEKO (Erstattungskodex) | |
| Austria | Astec 70 mcg/h transdermales Pflaster | — | 5St | green box | eEKO (Erstattungskodex) | |
| Austria | Astec 70 mcg/h transdermales Pflaster | — | 10St | green box | eEKO (Erstattungskodex) | |
| Austria | Bupensan 12 mg Sublingualtabl. | — | 28St | yellow box | eEKO (Erstattungskodex) | |
| Austria | Bupensan 12 mg Sublingualtabl. | — | 7St | yellow box | eEKO (Erstattungskodex) | |
| Bahrain | Butrans | Napp Pharmaceuticals Limited, Uk. | 10 MCG/HR | Transdermal Patch | POM | NHRA |
| Bahrain | Butrans | Napp Pharmaceuticals Limited, Uk. | 20 MCG/HR | Transdermal Patch | POM | NHRA |
| Bahrain | Butrans | Napp Pharmaceuticals Limited, Uk. | 5 MCG/HR | Transdermal Patch | POM | NHRA |
| Bulgaria | Buprenorphin Actavis | Teva B.V. | 70 micrograms/h transdermal patch | пластир трансдермален | По лекарско предписание | BDA |
| Bulgaria | Buprenorphin Actavis | Teva B.V. | 52,5 micrograms/h transdermal patch | пластир трансдермален | По лекарско предписание | BDA |
| Bulgaria | Buprenorphin Actavis | Teva B.V. | 35 micrograms/h transdermal patch | пластир трансдермален | По лекарско предписание | BDA |
| Bulgaria | Buprenorphin G.L. | G.L. Pharma GmbH | 8 mg sublingual tablets | сублингвални таблетки | По лекарско предписание | BDA |
| Bulgaria | Buprenorphin G.L. | G.L. Pharma GmbH | 4 mg sublingual tablets | сублингвални таблетки | По лекарско предписание | BDA |
| Bulgaria | Buprenorphin G.L. | G.L. Pharma GmbH | 2 mg sublingual tablets | сублингвални таблетки | По лекарско предписание | BDA |
| Croatia | Buprenorfin Alkaloid | Alkaloid d.o.o. | tbl. subllingv. 7x8 mg | RS | HZZO | |
| Croatia | Buprenorfin Alkaloid | Alkaloid d.o.o. | tbl. sublingv. 7x2 mg | RS | HZZO | |
| Croatia | Buprenorfin Sandoz | Sandoz d.o.o. | tbl. sublingv. 7x2 mg | RS | HZZO | |
| Croatia | Buprenorfin Sandoz | Sandoz d.o.o. | tbl. subllingv. 7x8 mg | RS | HZZO | |
| Croatia | Subutex | Indivior Europe Limited | tbl. sublingv. 7x2 mg | RS | HZZO | |
| Croatia | Subutex | Indivior Europe Limited | tbl. sublingv. 7x8 mg | RS | HZZO | |
| Croatia | Transtec | Grünenthal GmbH | flaster transd. 8x30 mg (52,50 mcg/h) | R | HZZO | |
| Croatia | Transtec | Grünenthal GmbH | flaster transd. 4x20 mg (35 mcg/h) | R | HZZO | |
| Czech Republic | Addnok | — | 2MG | Slg Tbl Nob | R | SUKL DLP |
| Czech Republic | Addnok | — | 8MG | Slg Tbl Nob | R | SUKL DLP |
| Czech Republic | Bupensanduo | — | 8MG/2MG | Slg Tbl Nob | R | SUKL DLP |
| Czech Republic | Buprenorfin Mylan | VIATRIS LIMITED, Dublin | 35MCG/H | Tdr Emp | B | SUKL DLP |
| Czech Republic | Buprenorfin Stada | — | 40MCG/H | Tdr Emp | R | SUKL DLP |
| Czech Republic | Buprenorfin Stada | — | 10MCG/H | Tdr Emp | R | SUKL DLP |
| Czech Republic | Buprenorfin Stada | — | 20MCG/H | Tdr Emp | R | SUKL DLP |
| Czech Republic | Buprenorfin Stada | — | 5MCG/H | Tdr Emp | R | SUKL DLP |
| Denmark | Bupaq Multidose Vet. | VetViva Richter GmbH | 0,3 mg/ml | injektionsvæske, opløsning | MRP | Laegemiddelstyrelsen |
| Denmark | Bupaq Vet. | VetViva Richter GmbH | 0,3 mg/ml | injektionsvæske, opløsning | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Bupranord Vet. | Alfasan Nederland BV | 0,3 mg/ml | injektionsvæske, opløsning | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Bupredine Vet. | Le Vet Beheer B.V. | 0,3 mg/ml | injektionsvæske, opløsning | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Buprefarm | Orifarm Generics A/S | 30 mikrogram/time | depotplastre | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Buprefarm | Orifarm Generics A/S | 25 mikrogram/time | depotplastre | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Buprefarm | Orifarm Generics A/S | 20 mikrogram/time | depotplastre | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Buprefarm | Orifarm Generics A/S | 10 mikrogram/time | depotplastre | Decentral procedure | Laegemiddelstyrelsen |
| European Union (EMA) | Buprenorphine Neuraxpharm | Neuraxpharm Pharmaceuticals S.L. | Authorised | EMA centrally authorised | ||
| European Union (EMA) | Buvidal | Camurus AB | Authorised | EMA centrally authorised | ||
| European Union (EMA) | Sixmo | L. Molteni & C. dei Fratelli Alitti Società di Esercizio S.p.A. | Withdrawn | EMA centrally authorised | ||
| Finland | Bupaq Multidose vet | VetViva Richter GmbH | 0.3 mg/ml | injektioneste, liuos | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Buprefarm | Orifarm Generics A/S | 15 mikrog/tunti | depotlaastari | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Buprefarm | Orifarm Generics A/S | 25 mikrog/tunti | depotlaastari | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Buprefarm | Orifarm Generics A/S | 10 mikrog/tunti | depotlaastari | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Buprefarm | Orifarm Generics A/S | 20 mikrog/tunti | depotlaastari | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Buprefarm | Orifarm Generics A/S | 5 mikrog/tunti | depotlaastari | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Buprefarm | Orifarm Generics A/S | 40 mikrog/tunti | depotlaastari | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Buprefarm | Orifarm Generics A/S | 30 mikrog/tunti | depotlaastari | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Greece | BUVIDAL INJ.SOL.PR 128MG/PF.SYR BTx1 PF.SYR x 0,36ML ΜΕ ΔΙΑΤΑΞΗ ΑΣΦΑΛΕΙΑΣ ΚΑΙ 1 ΡΑΒΔΟ ΕΜΒΟΛΟΥ | Camurus Ab, Sweden | reimbursed | MoH deltio timwn | ||
| Greece | BUVIDAL INJ.SOL.PR 16MG/PF.SYR BTx1 PF.SYR x 0,32ML ΜΕ ΔΙΑΤΑΞΗ ΑΣΦΑΛΕΙΑΣ ΚΑΙ 1 ΡΑΒΔΟ ΕΜΒΟΛΟΥ | Camurus Ab, Sweden | reimbursed | MoH deltio timwn | ||
| Greece | BUVIDAL INJ.SOL.PR 24MG/PF.SYR BTx1 PF.SYR x 0,48ML ΜΕ ΔΙΑΤΑΞΗ ΑΣΦΑΛΕΙΑΣ ΚΑΙ 1 ΡΑΒΔΟ ΕΜΒΟΛΟΥ | Camurus Ab, Sweden | reimbursed | MoH deltio timwn | ||
| Greece | BUVIDAL INJ.SOL.PR 32MG/PF.SYR BTx1 PF.SYR x 0,64ML ΜΕ ΔΙΑΤΑΞΗ ΑΣΦΑΛΕΙΑΣ ΚΑΙ 1 ΡΑΒΔΟ ΕΜΒΟΛΟΥ | Camurus Ab, Sweden | reimbursed | MoH deltio timwn | ||
| Greece | BUVIDAL INJ.SOL.PR 64MG/PF.SYR BTx1 PF.SYR x 0,18ML ΜΕ ΔΙΑΤΑΞΗ ΑΣΦΑΛΕΙΑΣ ΚΑΙ 1 ΡΑΒΔΟ ΕΜΒΟΛΟΥ | Camurus Ab, Sweden | reimbursed | MoH deltio timwn | ||
| Greece | BUVIDAL INJ.SOL.PR 8MG/PF.SYR BTx1 PF.SYR x 0,16ML ΜΕ ΔΙΑΤΑΞΗ ΑΣΦΑΛΕΙΑΣ ΚΑΙ 1 ΡΑΒΔΟ ΕΜΒΟΛΟΥ | Camurus Ab, Sweden | reimbursed | MoH deltio timwn | ||
| Greece | BUVIDAL INJ.SOL.PR 96MG/PF.SYR BTx1 PF.SYR x 0,27ML ΜΕ ΔΙΑΤΑΞΗ ΑΣΦΑΛΕΙΑΣ ΚΑΙ 1 ΡΑΒΔΟ ΕΜΒΟΛΟΥ | Camurus Ab, Sweden | reimbursed | MoH deltio timwn | ||
| Greece | LIBROXAR SUBL.TAB (2+0.5)MG/TAB BTx7 tabs (σε blisters OPA/AL/PVC/AL) | Rafarm A.e.b.e. | reimbursed | MoH deltio timwn | ||
| Iceland | Bupredine vet | Le Vet Beheer B.V. | 0,3 mg/ml | stl | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Buprenorphine Alvogen | Alvogen | 10 mcg/klst | forðapl | 2 | Lyfjastofnun lyfjaverdskra |
| Iceland | Buprenorphine Alvogen | Alvogen | 20 mcg/klst | forðapl | 2 | Lyfjastofnun lyfjaverdskra |
| Iceland | Buprenorphine Alvogen | Alvogen | 5 mcg/klst | forðapl | 2 | Lyfjastofnun lyfjaverdskra |
| Iceland | Buvidal | Camurus AB | 16 mg | stl | 4 | Lyfjastofnun lyfjaverdskra |
| Iceland | Buvidal | Camurus AB | 128 mg | stl | 4 | Lyfjastofnun lyfjaverdskra |
| Iceland | Buvidal | Camurus AB | 96 mg | stl | 4 | Lyfjastofnun lyfjaverdskra |
| Iceland | Buvidal | Camurus AB | 32 mg | stl | 4 | Lyfjastofnun lyfjaverdskra |
| Ireland | Buprenorphine 0.4 mg Sublingual Tablets | Activase Pharmaceuticals Limited | Sublingual tablet | Not marketed | HPRA | |
| Ireland | Buprenorphine 2 mg Sublingual Tablets | Aspire Pharma (Malta) Limited | Sublingual tablet | Not marketed | HPRA | |
| Ireland | Buprenorphine 2 mg Sublingual Tablets | Activase Pharmaceuticals Limited | Sublingual tablet | Not marketed | HPRA | |
| Ireland | Buprenorphine 8 mg Sublingual Tablets | Aspire Pharma (Malta) Limited | Sublingual tablet | Not marketed | HPRA | |
| Ireland | Buprenorphine 8 mg Sublingual Tablets | Activase Pharmaceuticals Limited | Sublingual tablet | Not marketed | HPRA | |
| Ireland | Buprenorphine Neuraxpharm | Laboratorios Lesvi, S.L. | Sublingual film | Unknown | HPRA | |
| Ireland | Buprenorphine Neuraxpharm | Laboratorios Lesvi, S.L. | Sublingual film | Unknown | HPRA | |
| Ireland | Buprenorphine Neuraxpharm | Laboratorios Lesvi, S.L. | Sublingual film | Unknown | HPRA | |
| Luxembourg | Temgesic Sublingualis CPR.SUBLING. 0,2 mg 1*50 cpr.ss blist. | — | S | CNS liste positive | ||
| Luxembourg | TRANSTEC 35MCG/H DISP.TRANSDERM. 20 mg 1*5 disp.tranderm. | — | S | CNS liste positive | ||
| Luxembourg | TRANSTEC 52,5MCG/H DISP.TRANSDERM. 30 mg 1*5 disp.tranderm. | — | S | CNS liste positive | ||
| Luxembourg | TRANSTEC 70MCG/H DISP.TRANSDERM. 40 mg 1*5 disp.tranderm. | — | S | CNS liste positive | ||
| MA | Temgesic | — | 0.3 MG/ML | Solution Injectable | P | CNOPS liste des medicaments |
| MA | Temgesic | — | 0.2 MG | Comprime Sublingual | P | CNOPS liste des medicaments |
| Malta | Addictex 0.4mg sublingual Tablets | Actavis Group PTC ehf | Sublingual Tablet | Withdrawn | Medicines Authority | |
| Malta | Addictex 2mg sublingual Tablets | Actavis Group PTC ehf | Sublingual Tablet | Withdrawn | Medicines Authority | |
| Malta | Addictex 8mg sublingual Tablets | Actavis Group PTC ehf | Sublingual Tablet | Withdrawn | Medicines Authority | |
| Malta | Buprenorphin - 1 A Pharma Transdermal Patch 35mcg/hr | 1 A Pharma GmbH | Transdermal Patch | Withdrawn | Medicines Authority | |
| Malta | Buprenorphine 0.4mg Sublingual Tablets | Martindale Pharmaceuticals Limited | Sublingual Tablet | Withdrawn | Medicines Authority | |
| Malta | Buprenorphine 1mg Sublingual Tablets | Martindale Pharmaceuticals Limited | Sublingual Tablet | Withdrawn | Medicines Authority | |
| Malta | Buprenorphine 2mg Sublingual Tablets | Martindale Pharmaceuticals Limited | Sublingual Tablet | Withdrawn | Medicines Authority | |
| Malta | Buprenorphine 2mg Sublingual Tablets; Natzon 2mg Sublingual Tablets | Aspire Pharma (Malta) Limited | Sublingual Tablet | Authorised | Medicines Authority | |
| Netherlands | Bunalict 2 mg/0,5 mg, tabletten voor sublinguaal gebruik | Sandoz B.V. | Tablet voor sublinguaal gebruik | Uitsluitend recept | EU national register | |
| Netherlands | Bunalict 8 mg/2 mg, tabletten voor sublinguaal gebruik | Sandoz B.V. | Tablet voor sublinguaal gebruik | Uitsluitend recept | EU national register | |
| Netherlands | Buprenorfine Glenmark 10 microgram/uur 7 dagen pleister voor transdermaal gebruik | Glenmark Arzneimittel GmbH | Pleister voor transdermaal gebruik | Uitsluitend recept | EU national register | |
| Netherlands | Buprenorfine Glenmark 15 microgram/uur 7 dagen pleister voor transdermaal gebruik | Glenmark Arzneimittel GmbH | Pleister voor transdermaal gebruik | Uitsluitend recept | EU national register | |
| Netherlands | Buprenorfine Glenmark 20 microgram/uur 7 dagen pleister voor transdermaal gebruik | Glenmark Arzneimittel GmbH | Pleister voor transdermaal gebruik | Uitsluitend recept | EU national register | |
| Netherlands | Buprenorfine Glenmark 30 microgram/uur 7 dagen pleister voor transdermaal gebruik | Glenmark Arzneimittel GmbH | Pleister voor transdermaal gebruik | Uitsluitend recept | EU national register | |
| Netherlands | Buprenorfine Glenmark 40 microgram/uur 7 dagen pleister voor transdermaal gebruik | Glenmark Arzneimittel GmbH | Pleister voor transdermaal gebruik | Uitsluitend recept | EU national register | |
| Netherlands | Buprenorfine Glenmark 5 microgram/uur 7 dagen pleister voor transdermaal gebruik | Glenmark Arzneimittel GmbH | Pleister voor transdermaal gebruik | Uitsluitend recept | EU national register | |
| Norway | Bugnanto depotplaster 10 mikrog/time | Sandoz - København | 4 | Depotplaster | Aktiv oppføring | FEST (DMP) |
| Norway | Bugnanto depotplaster 15 mikrog/time | Sandoz - København | 4 x 1 | Depotplaster | Aktiv oppføring | FEST (DMP) |
| Norway | Bugnanto depotplaster 20 mikrog/time | Sandoz - København | 4 | Depotplaster | Aktiv oppføring | FEST (DMP) |
| Norway | Bugnanto depotplaster 30 mikrog/time | Sandoz - København | 4 | Depotplaster | Aktiv oppføring | FEST (DMP) |
| Norway | Bugnanto depotplaster 5 mikrog/time | Sandoz - København | 4 | Depotplaster | Aktiv oppføring | FEST (DMP) |
| Norway | Buprefarm depotplaster 10 mikrog/time | Orifarm Generics A/S | 4 x 1 | Depotplaster | Aktiv oppføring | FEST (DMP) |
| Norway | Buprefarm depotplaster 15 mikrog/time | Orifarm Generics A/S | 4 x 1 | Depotplaster | Aktiv oppføring | FEST (DMP) |
| Norway | Buprefarm depotplaster 20 mikrog/time | Orifarm Generics A/S | 4 x 1 | Depotplaster | Aktiv oppføring | FEST (DMP) |
| Poland | Bunondol | Zakłady Farmaceutyczne POLPHARMA S.A. | 0,2 mg | Tabletki podjęzykowe | Bezterminowe | URPL RPL |
| Poland | Bunondol | Zakłady Farmaceutyczne POLPHARMA S.A. | 0,4 mg | Tabletki podjęzykowe | Bezterminowe | URPL RPL |
| Poland | Bunondol | Zakłady Farmaceutyczne POLPHARMA S.A. | 0,3 mg/ml | Roztwór do wstrzykiwań | Bezterminowe | URPL RPL |
| Poland | Bunorfin | L.Molteni & C. dei F.lli Alitti Societa di Esercizio S.p.A. | 2 mg | Tabletki podjęzykowe | Bezterminowe | URPL RPL |
| Poland | Bunorfin | L.Molteni & C. dei F.lli Alitti Societa di Esercizio S.p.A. | 8 mg | Tabletki podjęzykowe | Bezterminowe | URPL RPL |
| Poland | Bupranord | Alfasan Nederland BV | 0,300 mg/ml (co odpowiada 0,323 mg/ml buprenorfiny chlorowodorku) | Roztwór do wstrzykiwań | Bezterminowe | URPL RPL |
See every manufacturer of Buprenorphine (Buprenorphine Hydrochloride) worldwide →
Regulator price references for Buprenorphine (Buprenorphine Hydrochloride)
Published list or reimbursement prices for Buprenorphine (Buprenorphine Hydrochloride) presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Australia | Buprenorphine Sandoz | Transdermal patch 5 mg | 7.01 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | B-Patch | Transdermal patch 10 mg | 12.62 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Bupredermal | Transdermal patch 15 mg | 16.04 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Buprenorphine Sandoz | Transdermal patch 15 mg | 16.04 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Bupredermal | Transdermal patch 20 mg | 19.47 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Bupredermal | Transdermal patch 25 mg | 22.71 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Norspan | Transdermal patch 25 mg | 22.71 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Bupredermal | Transdermal patch 30 mg | 25.95 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Bupredermal | Transdermal patch 30 mg | 25.95 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Bupredermal | Transdermal patch 40 mg | 32.45 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Buprenorphine Sandoz | Transdermal patch 40 mg | 32.45 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Buvidal Weekly | Injection (modified release) 24 mg in 0.48 mL pre-filled syringe | 87.78 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Austria | Buprenorphin "ratiopharm" 5 mcg/h transdermales Pflaster | 0.005mg | 2St | 4.65 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Bupensan 2 mg Sublingualtabl. | 2mg | 7St | 4.80 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Buprenorphin "Hexal" 2 mg Sublingualtabl. | 2mg | 7St | 4.80 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Bupensan Duo 2 mg/0,5 mg Sublingualtabl. | 2mg/0.5mg | 7St | 5.95 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Temgesic 0,2 mg Sublingualtabl. | 0.2mg | 10St | 6.55 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Buprenorphin "ratiopharm" 10 mcg/h transdermales Pflaster | 0.01mg | 2St | 7.40 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Bupensan 4 mg Sublingualtabl. | 4mg | 7St | 7.65 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Temgesic 0,4 mg Sublingualtabl. | 0.4mg | 10St | 7.75 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Buprenorphin "ratiopharm" 5 mcg/h transdermales Pflaster | 0.005mg | 4St | 8.75 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Bupensan Duo 4 mg/1 mg Sublingualtabl. | 4mg/1mg | 7St | 9.55 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Buprenorphin "ratiopharm" 20 mcg/h transdermales Pflaster | 0.02mg | 2St | 11.75 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Bupensan 8 mg Sublingualtabl. | 8mg | 7St | 12.85 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Buprenorphin "Hexal" 8 mg Sublingualtabl. | 8mg | 7St | 12.85 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Buprenorphin "ratiopharm" 10 mcg/h transdermales Pflaster | 0.01mg | 4St | 13.90 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Astec 35 mcg/h transdermales Pflaster | 0.035mg | 5St | 14.25 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Bupretec 35 mcg/h transdermales Matrixpflaster | 0.035mg | 4St | 14.95 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Bupensan Duo 8 mg/2 mg Sublingualtabl. | 8mg/2mg | 7St | 14.95 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Buprenorphin "ratiopharm" 35 mcg/h transdermales Pflaster | 0.035mg | 4St | 14.95 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Bupretec 52,5 mcg/h transdermales Matrixpflaster | 0.0525mg | 4St | 14.95 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Bupretec 70 mcg/h transdermales Matrixpflaster | 0.07mg | 4St | 14.95 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Buprenorphin "Stada" 35 mcg/h transdermales Pflaster | 0.035mg | 4St | 14.95 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Buprenorphin "Stada" 52,5 mcg/h transdermales Pflaster | 0.0525mg | 4St | 14.95 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Buprenorphin "Stada" 70 mcg/h transdermales Pflaster | 0.07mg | 4St | 14.95 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Transtec 52,5 mcg/h transdermales Pflaster | 0.0525mg | 4St | 14.95 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Transtec 35 mcg/h transdermales Pflaster | 0.035mg | 4St | 14.95 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Bupensan 2 mg Sublingualtabl. | 2mg | 28St | 16.80 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Bupensan 12 mg Sublingualtabl. | 12mg | 7St | 16.90 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Transtec 70 mcg/h transdermales Pflaster | 0.07mg | 4St | 17.85 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Buprenorphin "ratiopharm" 52,5 mcg/h transdermales Pflaster | 0.0525mg | 4St | 17.85 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Buprenorphin "Hexal" 2 mg Sublingualtabl. | 2mg | 30St | 18.00 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Astec 52,5 mcg/h transdermales Pflaster | 0.0525mg | 5St | 18.10 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Bupensan 16 mg Sublingualtabl. | 16mg | 7St | 20.40 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Bupensan Duo 2 mg/0,5 mg Sublingualtabl. | 2mg/0.5mg | 28St | 20.85 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Temgesic 0,2 mg Sublingualtabl. | 0.2mg | 50St | 22.05 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Buprenorphin "ratiopharm" 20 mcg/h transdermales Pflaster | 0.02mg | 4St | 22.20 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Astec 70 mcg/h transdermales Pflaster | 0.07mg | 5St | 22.60 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Astec 35 mcg/h transdermales Pflaster | 0.035mg | 10St | 27.10 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Bupensan 4 mg Sublingualtabl. | 4mg | 28St | 27.25 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Bupretec 70 mcg/h transdermales Matrixpflaster | 0.07mg | 8St | 28.25 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Bupretec 52,5 mcg/h transdermales Matrixpflaster | 0.0525mg | 8St | 28.25 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Bupretec 35 mcg/h transdermales Matrixpflaster | 0.035mg | 8St | 28.25 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Bupensan Duo 4 mg/1 mg Sublingualtabl. | 4mg/1mg | 28St | 33.65 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Astec 52,5 mcg/h transdermales Pflaster | 0.0525mg | 10St | 34.25 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Temgesic 0,4 mg Sublingualtabl. | 0.4mg | 50St | 40.40 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Astec 70 mcg/h transdermales Pflaster | 0.07mg | 10St | 42.40 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Bupensan 8 mg Sublingualtabl. | 8mg | 28St | 45.65 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Buprenorphin "Hexal" 8 mg Sublingualtabl. | 8mg | 30St | 48.95 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Bupensan Duo 8 mg/2 mg Sublingualtabl. | 8mg/2mg | 28St | 54.20 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Bupensan 12 mg Sublingualtabl. | 12mg | 28St | 61.45 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Bupensan 16 mg Sublingualtabl. | 16mg | 28St | 75.90 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Buvidal 24 mg Depot-Inj.lsg. | 24mg | 1St | 95.25 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Buvidal 16 mg Depot-Inj.lsg. | 16mg | 1St | 95.25 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Buvidal 8 mg Depot-Inj.lsg. | 8mg | 1St | 95.25 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Buvidal 32 mg Depot-Inj.lsg. | 32mg | 1St | 95.25 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Buvidal 96 mg Depot-Inj.lsg. | 96mg | 1St | 342.40 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Buvidal 128 mg Depot-Inj.lsg. | 128mg | 1St | 342.40 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Buvidal 160 mg Depot-Inj.lsg. | 160mg | 1St | 342.40 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Buvidal 64 mg Depot-Inj.lsg. | 64mg | 1St | 342.40 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| United Arab Emirates | BuTrans® 5 microgram/hour | 4 Patches | 143.00 AED | public | EDE | 2026-08-31 | |
| United Arab Emirates | BuTrans® 10 microgram/hour | 4 Patches | 256.00 AED | public | EDE | 2026-08-31 | |
| United Arab Emirates | Buvidal® 32 mg/0.64 mL | 32mg/0.64ml | 1 Pre-filled Syringe (0.64 mL) | 405.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Buvidal® 24 mg/0.48 mL | 24mg/0.48ml | 1 Pre-filled Syringe (0.48 mL) | 405.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Buvidal® 8 mg/0.16 mL | 8mg/0.16ml | 1 Pre-filled Syringe (0.16 mL) | 405.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Buvidal® 16 mg/0.32 mL | 16mg/0.32ml | 1 Pre-filled Syringe (0.32 mL) | 405.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | BuTrans® 20 microgram/hour | 4 Patches | 453.50 AED | public | EDE | 2026-08-31 | |
| United Arab Emirates | Buvidal® 128 mg/0.36 mL | 128mg/0.36ml | 1 Pre-filled Syringe(0.36 mL) | 1,722.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Buvidal® 96 mg/0.27 mL | 96mg/0.27ml | 1 Pre-filled Syringe(0.27 mL) | 1,722.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Buvidal® 64 mg/0.18 mL | 64mg/0.18ml | 1 Pre-filled Syringe (0.18 mL) | 1,722.00 AED | public | EDE | 2026-08-31 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Buprixa (DIN 02542536) marketed in Canada?
No. Health Canada lists DIN 02542536 as Approved as of 30 Jan 2024.
Who holds the Canadian licence for this product?
Zoetis Canada Inc is the company of record in the Health Canada Drug Product Database.
Is Buprenorphine (Buprenorphine Hydrochloride) registered outside Canada?
Yes — Nexara Health has matched 862 registrations in 28 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02542536, status date 2024-01-30; national medicine registries: BDA, CNOPS liste des medicaments, CNS liste positive, eEKO (Erstattungskodex), EMA centrally authorised, EU national register, FEST (DMP), Fimea Perusrekisteri, HPRA, HZZO, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, Medicines Authority, MoH deltio timwn, NHRA, PBS, SUKL DLP, URPL RPL; price sources: EDE, eEKO (Erstattungskodex), PBS. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02542536, status date 2024-01-30; national medicine registries: BDA, CNOPS liste des medicaments, CNS liste positive, eEKO (Erstattungskodex), EMA centrally authorised, EU national register, FEST (DMP), Fimea Perusrekisteri, HPRA, HZZO, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, Medicines Authority, MoH deltio timwn, NHRA, PBS, SUKL DLP, URPL RPL; price sources: EDE, eEKO (Erstattungskodex), PBS.
Zoetis Canada Inc — company profileWho else makes Buprenorphine (Buprenorphine Hydrochloride)All Canadian Buprenorphine (Buprenorphine Hydrochloride) products
Health Canada Drug Product Database (DPD), DIN 02542536, status date 2024-01-30; national medicine registries: BDA, CNOPS liste des medicaments, CNS liste positive, eEKO (Erstattungskodex), EMA centrally authorised, EU national register, FEST (DMP), Fimea Perusrekisteri, HPRA, HZZO, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, Medicines Authority, MoH deltio timwn, NHRA, PBS, SUKL DLP, URPL RPL; price sources: EDE, eEKO (Erstattungskodex), PBS. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.